The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review.
Kaeshaelya ThiruchelvamChia Siang Chia KowMuhammad Abdul HadiSyed Shahzad HasanPublished in: Expert review of anti-infective therapy (2021)
Given the current evidence, there is insufficient data to confidently recommend the use of remdesivir alone for the treatment of adult hospitalized patients with moderate-to-severe COVID-19. However, remdesivir may be considered along with an anti-inflammatory agent in patients with pneumonia, on oxygen support, provided there is close monitoring of clinical and laboratory parameters and adverse events.